Cymbalta Withdrawal Litigation
Baum, Hedlund, Aristei & Goldman has the most experience in antidepressant litigation of any other plaintiffs’ law firm in the country. The firm also has the longest track record handling antidepressant personal injury and wrongful death cases and remains at the forefront of the antidepressant suicide, withdrawal, and birth defect litigation. Baum Hedlund has handled over 4,500 cases against the makers of Prozac, Paxil, Zoloft, Effexor, Celexa, Lexapro and Cymbalta, since 1990.
The firm also helped bring about the black box suicidality warning for children and young adults, now on most antidepressant labels, and they were the law firm that found the internal drug company study linking SSRIs to cardio birth defects.
Over the past 40 years Baum Hedlund has recovered more than $1.9 billion for their clients in all types of personal injury and wrongful death litigation. The firm’s lawyers are also consumer advocates who have testified before state and federal governments on numerous occasions in order to improve consumer and product safety. Many of the lawyers have also served in leadership positions on 23 Plaintiffs’ Steering Committees, which oversee complex cases in multi-district litigation.
Baum Hedlund is listed in the 2016 Top Ranked Law Firms™ because the majority of its attorneys have an AV Preeminent® Peer Review Rating, is listed in The Best Lawyers in America®, and Martindale Hubbell’s Bar Register of Preeminent Lawyers. The firm is proud to be a Patron of the Leader’s Forum of the American Association for Justice.
Each Cymbalta lawyer from Baum Hedlund is working together on many Cymbalta lawsuits across the country with Cymbalta lawyer teams from Keller Rohrback L.L.P. and Pogust Braslow & Millrood.